Month: August 2020

MONTREAL, Quebec and SARASOTA, Fla., Aug. 12, 2020 (GLOBE NEWSWIRE) — Intertape Polymer Group Inc. (TSX:ITP)AN ACCOMPANYING PRESENTATION WILL ALSO BE AVAILABLE. DETAILS FOR ACCESS WILL BE INCLUDED IN THE SECOND QUARTER PRESS RELEASE.CONFERENCE CALL WILL BE AVAILABLE BY WEBCASTClick on following link to pre-registerhttps://onlinexperiences.com/Launch/QReg/ShowUUID=C6267415-2F7C-4F0B-9144-B72043E11FF9 DIGITIZED REPLAYSECOND QUARTER RESULTS WILL BE PUBLISHED BEFOREMARKET OPENS, AUGUST 13 THROUGH GLOBENEWSWIRE.For further information, please contact:Ross MarshallLodeRock Advisors, Inc.Tel : (416) 526-1563

New York, Aug. 12, 2020 (GLOBE NEWSWIRE) — Cyber security service provider Lodestone Security, a wholly owned subsidiary of Beazley, has appointed Frank Luzsicza as CEO.Frank will lead Lodestone’s cyber security and breach response teams in helping clients in North America to build their resilience and manage an incident should one occur.He brings over two decades of experience in cyber security, technology and risk management to Lodestone Security and joins from TÜV Rheinland Group where he was executive vice president and a member of the group executive council. Frank was responsible for the firm’s end-to-end global cyber security and digital services business. Before TÜV Rheinland Group, Frank held leadership positions at IBM Security and was an active board member supporting the cyber security start-up community.Lodestone Security...

Initiated a Phase 2 Open Angle Glaucoma Trial; Recruiting Ahead of ScheduleAnnounced Partnership with I-SPY to Participate in a Clinical Trial to Treat ARDS in COVID-19 PatientsAnnounced a Second Clinical Trial Funded in Part by the U.S. Military to Prevent ARDS in COVID-19 PatientsEnded Second Quarter 2020 with $44.9 Million in CashConference Call Today, August 12, 2020 at 8:30 a.m. EDTCINCINNATI, Aug. 12, 2020 (GLOBE NEWSWIRE) — Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, as well as other indications in which the Company believes that activation of Tie2 may have therapeutic potential, including acute respiratory distress syndrome (“ARDS”) associated with COVID-19 infections, today reported...

MINNEAPOLIS, Aug. 12, 2020 (GLOBE NEWSWIRE) — iMedia Brands, Inc. (NASDAQ: IMBI) has appointed Darryl Porter to its board of directors, effective August 11, 2020.Mr. Porter is a proven media executive with over 30 years of diversified business and creative experience in television, film and music. He is the CEO of Iconic Spectrum, a licensing company that specializes in monetizing African American icons like Miles Davis and George Duke across all forms of media. Prior to Iconic Spectrum, Mr. Porter served as CEO of Underworld Entertainment, a Disney-affiliated, feature film production company. During his tenure, Underworld developed notable films such as “Dead Presidents” and “Menace II Society.” Earlier in his career, Mr. Porter was VP, Business Affairs at Tribune Entertainment. He began his career at the law firm of Schuyler,...

IRVINE, Calif., Aug. 12, 2020 (GLOBE NEWSWIRE) — Lantronix, Inc. (NASDAQ: LTRX), a global provider of intelligent edge and secure data management solutions for the Industrial Internet of Things (IoT), today announced its new Lantronix Open-Q™ 610 μSOM. Scheduled for delivery later this year, the advanced Lantronix Open-Q 610 μSOM will be aimed at connected visual intelligence applications with high-resolution camera capabilities, on-device artificial intelligence (AI) processing and native Ethernet interface.“Lantronix micro SOMs and solutions enable IoT device makers to jumpstart new product development and accelerate time-to-market by shortening the design cycle, reducing development risk and simplifying the manufacturing process,” said Paul Pickle, CEO of Lantronix.The new Lantronix ultra-compact (50mm x 25mm), production-ready...

COPENHAGEN, Denmark, Aug. 12, 2020 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to address unmet medical needs, today announced the European Commission (EC) has granted Orphan Designation to TransCon C-Type Natriuretic Peptide (CNP) for the treatment of achondroplasia, the most common form of dwarfism.1  TransCon CNP is a investigational long-acting prodrug of CNP, designed to provide continuous exposure of CNP at safe, therapeutic levels via a single, weekly subcutaneous dose.  TransCon CNP also received orphan designation for the treatment of achondroplasia in the United States (U.S.) in February 2019.  Currently, there is no medical therapy approved for the treatment of achondroplasia.2“We now have orphan designations in Europe and the U.S....

PEMBROKE, Bermuda, Aug. 12, 2020 (GLOBE NEWSWIRE) — Sompo International Holdings Ltd., a Bermuda-based specialty provider of property and casualty insurance and reinsurance, has appointed Mrs. Lauren Folkard, Vice President and Head of Cyber for the London Market. Mrs. Folkard was previously a cyber class underwriter at Barbican and is an industry veteran, having been part of the cyber management team at Chubb. She will be based out of the firm’s London office.Mr. Julian James, Chief Executive Officer, International Insurance at Sompo International, commented, “We are delighted to welcome Lauren to Sompo International. This is an exciting development as part of our long-term commitment to this class of business and it supplements our global cyber capabilities. While clients already face a wide range of cyber exposures, they have...

Second Quarter Revenues were $33.1 million, Compared to $35.3 million in 2019, First Half 2020 Revenues were $66.4 million, up 7% from 2019 Net Income for the Second Quarter and for the First Half of 2020 was $3.5 million and $8.7 million, Respectively, Compared to $6.1 million and $11.1 million in 2019 RespectivelySignificant Progress Achieved in Development of a Plasma-Derived Immunoglobulin (IgG) Product as a Potential Treatment for Coronavirus Disease (COVID-19)Approximately $100 million of Available Net Cash as of June 30, 2020Exploring Business Development Initiatives Targeted to Mitigate the Effect of the Planned Transition of GLASSIA® Manufacturing to Takeda During 2021Company Reiterates Full-Year 2020 Total Revenue Guidance of $132 Million to $137 MillionREHOVOT, Israel, Aug. 12, 2020 (GLOBE NEWSWIRE) — Kamada Ltd. (NASDAQ:...